SCHEMBL27925517

SCHEMBL27925517

Brc1cccc2nc(-c3ccccc3)sc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 2/20 0.45
KDM4E B2RXH2 6/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
MAPT P10636 4/20 0.42
ALDH1A1 P00352 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
GLA P06280 2/20 0.42
GAA P10253 2/20 0.42
PKM P14618 2/20 0.42
HPGD P15428 1/20 0.42
RAB9A P51151 7/20 0.42
NPC1 O15118 5/20 0.42
NFKB1 P19838 4/20 0.42
NFKB2 Q00653 4/20 0.42
RELA Q04206 4/20 0.42
TDP1 Q9NUW8 1/20 0.42
LMNA P02545 3/20 0.41
TP53 P04637 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30903623 1.00 APP (0.45) APPKDM4ESMN1; SMN2MAPTALDH1A1
SCHEMBL13865431 0.81 TNF (0.60) APPKDM4ESMN1; SMN2MAPTALDH1A1
SCHEMBL2138067 0.79 APP (0.49) APPKDM4ESMN1; SMN2MAPTALDH1A1
SCHEMBL7298660 0.78 APP (0.42) APPKDM4ESMN1; SMN2MAPTALDH1A1
SCHEMBL4337306 0.77 APP (0.44) APPKDM4ESMN1; SMN2MAPTALDH1A1
SCHEMBL17856768 0.76 ADORA3 (0.45) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL28746028 0.76 SMN1; SMN2 (0.50) APPKDM4ESMN1; SMN2MAPTALDH1A1
SCHEMBL7299751 0.75 KDM4E (0.44) APPKDM4ESMN1; SMN2MAPTALDH1A1
SCHEMBL28598741 0.75 APP (0.49) APPKDM4ESMN1; SMN2MAPTALDH1A1
SCHEMBL5116616 0.75 SMN1; SMN2 (0.51) APPKDM4ESMN1; SMN2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240246996-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2024-07-25 US disclosed
US-20240246953-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND LG DISPLAY CO., LTD. (KR) 2024-07-25 US disclosed
US-20240246997-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2024-07-25 US disclosed
US-20240237519-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND LG DISPLAY CO., LTD. (KR) 2024-07-11 US disclosed
US-20240237519-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND LG DISPLAY CO., LTD. (KR) 2024-07-11 US disclosed
CN-118255784-A Organic compound, organic light emitting diode including the same, and organic light emitting device 乐金显示有限公司 2024-06-28 CN disclosed
CN-118255783-A Organic compound, organic light emitting diode including the same, and organic light emitting device 乐金显示有限公司 2024-06-28 CN disclosed
EP-4389851-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND LG Display Co., Ltd. (KR) 2024-06-26 EP disclosed
CN-118239943-A Organic compound, organic light emitting diode having the same, and organic light emitting device 乐金显示有限公司 2024-06-25 CN disclosed
CN-118239944-A Organic compound, organic light emitting diode having the same, and organic light emitting device 乐金显示有限公司 2024-06-25 CN disclosed
CN-103420936-A Method for performing microwave catalysis in aqueous phase to prepare benzothiazole compound UNIV FUJIAN MEDICAL 2013-12-04 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240246996-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME ORC3, PPOX, AOX1 APP 2029/4885KDM4E 1839/4885SMN1; SMN2 4262/4885
US-20240246997-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME ORC3, PPOX, AOX1 APP 2029/4885KDM4E 1839/4885SMN1; SMN2 4262/4885
US-20240246953-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND TELO2, ARNT, TYR APP 871/4885KDM4E 1580/4885SMN1; SMN2 2260/4885
US-20240237519-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND NLRP3, NLRP1, TYR APP 727/4885KDM4E 1611/4885SMN1; SMN2 2040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.